论文部分内容阅读
目的:评价法莫替丁与阿莫西林对消化性溃疡患者的临床疗效。方法:选取2014年5月—2015年5月间收治的消化性溃疡患者120例作为研究对象,按照随机数字表法将其分为观察组(n=60)和对照组(n=60);观察组患者均均给予法莫替丁治疗3月,并给予阿莫西林和甲硝唑辅助治疗15 d;对照组患者均给予法莫西林和胃舒平治疗3月,比较两组患者的临床疗效。结果:观察组患者治疗后的治愈率为93.33%显著高于对照组为66.67%(P<0.05)。结论:法莫替丁与抗菌药物联用对治疗消化性内科溃疡患者的临床疗效显著,优于单用法莫替丁的治疗。
Objective: To evaluate the clinical efficacy of famotidine and amoxicillin in patients with peptic ulcer. Methods: A total of 120 patients with peptic ulcer who were admitted to our hospital from May 2014 to May 2015 were selected as study subjects and divided into observation group (n = 60) and control group (n = 60) according to random number table. Patients in the observation group were treated with famotidine for 3 months, and received amoxicillin and metronidazole adjuvant therapy for 15 days. Patients in the control group were treated with famotidine and Wei Shuping for 3 months, and the clinical efficacy was compared between the two groups. Results: The cure rate of the observation group after treatment was 93.33%, which was significantly higher than that of the control group (66.67%, P <0.05). Conclusion: The combination of famotidine and antimicrobial agents has significant clinical effect on patients with peptic ulcer. It is superior to the single famotidine treatment.